A carregar...

Sequential Therapy with Nivolumab Followed by Ipilimumab Induces Complete Response in Metastatic Melanoma of the Lung but with Severe Hepatotoxicities

Since nivolumab significantly prolongs survival in patients with metastatic melanoma, the number of patients administered nivolumab is increasing, but only 30–40% of patients who received nivolumab monotherapy experienced objective tumor regression. Therefore, enhancing its anti-tumor immune respons...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Case Rep Oncol
Main Authors: Furudate, Sadanori, Fujimura, Taku, Kambayashi, Yumi, Hidaka, Takanori, Hashimoto, Akira, Aiba, Setsuya
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5118831/
https://ncbi.nlm.nih.gov/pubmed/27920696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000450974
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!